Widely used in identifying autoantibodies in autoimmune diseases (10), and recently used to identify ACAAs against B-cell activating factor (BAFF) in SLE (18) and ACAAs against type I IFNs in patients with RAG insufficiency. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.